Malicon

Citalopram, the active ingredient in Malicon, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adults. GNH USA supplies Malicon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Citalopram is an SSRI that acts on mood‑regulating pathways in the central nervous system. - Major depressive disorder: alleviates depressive symptoms and improves mood in diagnosed patients.

Citalopram may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset often occurring early in therapy. - Headache: transient tension‑type headaches reported by many patients. - Dry mouth: reduced salivary flow leading to a dry oral sensation. - Insomnia or somnolence: sleep disturbances or excessive drowsiness. - Sexual dysfunction: decreased libido or difficulty achieving orgasm. - Diarrhea: loose stools that usually resolve with continued use.

Serious or Rare Side Effects: - Serotonin syndrome: potentially life‑threatening condition with agitation, hyperthermia, and neuromuscular abnormalities. - QT interval prolongation: cardiac conduction changes that may predispose to arrhythmia. - Suicidal thoughts: emergence of suicidal ideation, especially in young adults. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Hyponatremia: low blood sodium levels that can cause confusion or seizures. - Bleeding abnormalities: increased risk of gastrointestinal or intracranial bleeding.

Citalopram requires careful monitoring to ensure safe use. - Suicidal risk assessment: evaluate for emergent suicidal thoughts, particularly during treatment initiation. - Cardiac monitoring: obtain baseline ECG and monitor QT interval in patients with cardiac risk factors. - Discontinuation syndrome: taper the dose gradually to avoid withdrawal symptoms. - Hepatic impairment: adjust dosing and monitor liver function in patients with liver disease. - Concomitant serotonergic agents: avoid combining with other SSRIs, SNRIs, or MAO inhibitors. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Citalopram can interact with several medication classes, altering efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: concurrent use can precipitate serotonin syndrome. - Other serotonergic drugs (e.g., SSRIs, SNRIs, tramadol, linezolid): increase risk of serotonin toxicity. - Pimozide: may cause severe cardiac arrhythmias when combined. - Certain antiarrhythmics (e.g., quinidine): can exacerbate QT prolongation.

Moderate Interactions (Monitor Closely): - NSAIDs or anticoagulants: heightened bleeding risk. - CYP2C19 inhibitors (e.g., omeprazole, fluconazole): may raise citalopram plasma levels. - Alcohol: can intensify central nervous system depression. - Diuretics: may worsen hyponatremia. - Antipsychotics (e.g., risperidone): potential additive QT effects.